Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Conroy

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Molecular Diagnosis & Therapy|June 7, 2025
Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue UsageMichelle F Green, Zachary D Wallen, Heidi C Ko, et al.
Journal for Immunotherapy of Cancer|August 21, 2023
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapyBettzy Stephen, Joud Hajjar, Shrutii Sarda, et al.
Journal of Personalized Medicine|May 25, 2024
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast CancerRobert J Seager, Heidi Ko, Sarabjot Pabla, et al.
Oncotarget|May 5, 2016
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulationJianmin Wang, Antonios Papanicolau-Sengos, Sreenivasulu Chintala, et al.
Human Molecular Genetics|April 4, 2023
Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosomeZhuo Xing, Yichen Li, Eduardo Cortes-Gomez, et al.
Journal of Translational Medicine|February 7, 2024
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancerR J Seager, Maria-Fernanda Senosain, Erik Van Roey, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
Breast Cancer (Dove Medical Press)|August 28, 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast CancerHeidi Chwan Ko, R J Seager, Sarabjot Pabla, et al.
SLAS Technology|February 1, 2025
Fully automated extraction of high-quality total nucleic acids from FFPE specimens for comprehensive genomic profiling of solid tumorsKristopher Amirault, Michael Collins, Luca Beker, et al.
The Journal of Molecular Diagnostics : JMD|August 24, 2018
OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric MalignanciesMatthew C Hiemenz, Dejerianne G Ostrow, Tracy M Busse, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Molecular Diagnosis & Therapy|June 7, 2025
Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue UsageMichelle F Green, Zachary D Wallen, Heidi C Ko, et al.
Journal for Immunotherapy of Cancer|August 21, 2023
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapyBettzy Stephen, Joud Hajjar, Shrutii Sarda, et al.
Journal of Personalized Medicine|May 25, 2024
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast CancerRobert J Seager, Heidi Ko, Sarabjot Pabla, et al.
Oncotarget|May 5, 2016
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulationJianmin Wang, Antonios Papanicolau-Sengos, Sreenivasulu Chintala, et al.
Human Molecular Genetics|April 4, 2023
Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosomeZhuo Xing, Yichen Li, Eduardo Cortes-Gomez, et al.
Journal of Translational Medicine|February 7, 2024
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancerR J Seager, Maria-Fernanda Senosain, Erik Van Roey, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
Breast Cancer (Dove Medical Press)|August 28, 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast CancerHeidi Chwan Ko, R J Seager, Sarabjot Pabla, et al.
SLAS Technology|February 1, 2025
Fully automated extraction of high-quality total nucleic acids from FFPE specimens for comprehensive genomic profiling of solid tumorsKristopher Amirault, Michael Collins, Luca Beker, et al.
The Journal of Molecular Diagnostics : JMD|August 24, 2018
OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric MalignanciesMatthew C Hiemenz, Dejerianne G Ostrow, Tracy M Busse, et al.
Pageof 7